Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supply of eculizumab to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Alexion Rare Disease part of Astra Zeneca | - | - | 1 lot Lot 1 | - |
| Amgen Ltd | 02354269 | - | 1 lot Lot 1 | - |
| Samsung Bioepis | 08840722 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £10,508,400 initial term | 3 | Amgen Ltd Alexion Rare Disease part of Astra Zeneca Samsung Bioepis | complete |
Weightings from the notice.
Government spending data: These suppliers have received £8,180,106 in 819 payments (over £25k) from Guy's and St Thomas' NHS FT, University Hospitals Bristol and Weston NHS FT, Manchester University NHS Foundation Trust, Department of Health and Social Care, Maidstone and Tunbridge Wells NHS Trust and 7 more public bodies (2019-04-17 to 2026-03-26).